World Health Organization Model List of Essential Medicines
E261826
The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
All labels observed (4)
How this entity was disambiguated
This entity first appeared as the object of triple T2370998 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: World Health Organization Model List of Essential Medicines Context triple: [Herceptin, isListedOn, World Health Organization Model List of Essential Medicines]
-
A.
Doha Declaration on the TRIPS Agreement and Public Health
The Doha Declaration on the TRIPS Agreement and Public Health is a 2001 WTO ministerial statement affirming that intellectual property rules should not prevent members from protecting public health and ensuring access to affordable medicines.
-
B.
World Health Report
The World Health Report is the World Health Organization’s flagship analytical publication that provides comprehensive assessments of global health trends, challenges, and policy priorities.
-
C.
International Classification of Health Interventions
The International Classification of Health Interventions is a standardized global system developed by the World Health Organization to categorize and code medical and health-related procedures and interventions for use in clinical practice, research, and health statistics.
-
D.
Constitution of the World Health Organization
The Constitution of the World Health Organization is the foundational treaty that established the WHO, defining its objectives, governance structure, and powers in global public health.
-
E.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: World Health Organization Model List of Essential Medicines Target entity description: The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
-
A.
Doha Declaration on the TRIPS Agreement and Public Health
The Doha Declaration on the TRIPS Agreement and Public Health is a 2001 WTO ministerial statement affirming that intellectual property rules should not prevent members from protecting public health and ensuring access to affordable medicines.
-
B.
World Health Report
The World Health Report is the World Health Organization’s flagship analytical publication that provides comprehensive assessments of global health trends, challenges, and policy priorities.
-
C.
International Classification of Health Interventions
The International Classification of Health Interventions is a standardized global system developed by the World Health Organization to categorize and code medical and health-related procedures and interventions for use in clinical practice, research, and health statistics.
-
D.
Constitution of the World Health Organization
The Constitution of the World Health Organization is the foundational treaty that established the WHO, defining its objectives, governance structure, and powers in global public health.
-
E.
Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
- F. None of above. chosen
Statements (56)
| Predicate | Object |
|---|---|
| instanceOf |
WHO guideline
ⓘ
essential medicines list ⓘ health policy instrument ⓘ |
| appliesToJurisdiction | worldwide ⓘ |
| author | World Health Organization ⓘ |
| countryOfOrigin | Switzerland ⓘ |
| covers |
child health conditions
ⓘ
communicable diseases ⓘ emergency care ⓘ maternal health conditions ⓘ noncommunicable diseases ⓘ |
| criterionUsed |
clinical efficacy
ⓘ
cost-effectiveness ⓘ public health relevance ⓘ safety ⓘ |
| governedBy | WHO Expert Committee on Selection and Use of Essential Medicines ⓘ |
| hasPart |
World Health Organization Model List of Essential Medicines
self-linksurface differs
ⓘ
surface form:
World Health Organization Model List of Essential Medicines for Children
|
| hasPurpose |
to guide national essential medicines lists
ⓘ
to identify medicines that satisfy the priority health care needs of the population ⓘ to promote equitable access to essential medicines ⓘ to support rational use of medicines ⓘ |
| hasSection |
analgesics
ⓘ
anesthetics ⓘ anti-infective medicines ⓘ antidiabetic medicines ⓘ antimalarials ⓘ antiretroviral medicines ⓘ antituberculosis medicines ⓘ cardiovascular medicines ⓘ vaccines and biologicals ⓘ |
| hasUpdateFrequency | every two years ⓘ |
| headquartersLocation | Geneva ⓘ |
| inception | 1977 ⓘ |
| includes |
complementary list of essential medicines
ⓘ
core list of essential medicines ⓘ |
| influences |
national essential medicines lists
ⓘ
procurement policies ⓘ reimbursement lists ⓘ |
| isAvailableAs | free online publication ⓘ |
| isPartOf |
World Health Organization Model List of Essential Medicines
self-linksurface differs
ⓘ
surface form:
World Health Organization essential medicines program
|
| language | English ⓘ |
| mainSubject |
access to medicines
ⓘ
essential medicines ⓘ pharmaceutical policy ⓘ public health ⓘ |
| publisher | World Health Organization ⓘ |
| reviewProcess |
evidence-based review
ⓘ
public consultation ⓘ |
| targetAudience |
clinical guideline developers
ⓘ
governments ⓘ health systems planners ⓘ |
| usedBy |
donor agencies
ⓘ
health policy makers ⓘ international organizations ⓘ national health authorities ⓘ non-governmental organizations ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: World Health Organization Model List of Essential Medicines Description of subject: The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
Referenced by (11)
Full triples — surface form annotated when it differs from this entity's canonical label.